Eagle Pharmaceuticals, Inc.: 25 filed Nov 26, 2024

Form type

25

Filing date

Nov 26, 2024

Accession number

0001104659-24-123086

Filer

Eagle Pharmaceuticals, Inc. (CIK 827871)